New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them?

Quick Read

Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”

Quick Read

Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs

Quick Read

Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

Summer Bummer

April 30, 2019

The snake struck a 9-year-old hiker at dusk on a nature trail. The outrageous bills struck her parents a few weeks later

Quick Read

With much fanfare, federal officials required hospitals nationwide this year to post their “list” prices online. But it’s not yet clear how many are doing it, even as the government has taken the rare step of asking consumers to monitor hospital compliance.

Quick Read

As pharmaceutical companies seek to profit from the curative wonders of human feces, doctors worry about new regulations, higher prices and patients attempting DIY cures

Quick Read